‘Ensuring Drug Security’ Russian Pharmaceutical Forum Announces Business Programme

The ‘Ensuring Drug Security’ Russian Pharmaceutical Forum has posted the event’s business programme on its official website. This key business event of the pharmaceutical industry will take place on the opening day of the 25th St. Petersburg International Economic Forum. The event is being organized by the Roscongress Foundation with the support of the Russian Ministry of Health and the Subcommittee on Drug Circulation and the Development of the Pharmaceutical and Medical Industry of the Russian State Duma’s Committee on Health Protection. The Forum is held annually and is a leading platform for discussing the business agenda of the pharmaceutical industry.

“The issue of drug security is a matter of national security and the health of our citizens, so improving the efficiency of our pharmaceutical industry in the new environment is a top priority. We must not only ensure the availability of drugs, but be certain that our citizens get access to the most effective modern medicines,” said Alexander Petrov, the subcommittee’s chairman.

In addition to Petrov, the Forum will be attended by: Russian Minister of Health Mikhail Murashko; Federation Council Deputy Chairwoman Galina Karelova; Russian Federal Medical-Biological Agency Director Veronika Skvortsova; Russian First Deputy Minister of Health Viktor Fisenko; Russian Deputy Minister of Health Sergey Glagolev; Russian Deputy Minister of Health Tatyana Semenova; Director of the National Medical Research Centre for Therapy and Preventive Medicine and Chief External Expert in Therapy and General Medical Practice of the Russian Ministry of Health Oksana Drapkina; Russian Federal Service for Surveillance in Healthcare Director Alla Samoylova; Director General of the Centre for Healthcare Quality Assessment and Control of the Russian Ministry of Health Vitaly Omelyanovsky; General Director of the Almazov National Medical Research Centre of the Russian Ministry of Health and President of the Russian Society of Cardiology Yevgeny Shlyakhto; Vice President of the Russian Academy of Sciences and Chair of the Medical Nanobiotechnologies Department at Pirogov Russian National Research Medical University Vladimir Chekhonin; Federal Antimonopoly Service Deputy Director Timofey Nizhegorodtsev; Secretary of the Russian Public Chamber and Chairwoman of the Board of the Private Law Research Centre under the Russian President Lidiya Mikheyeva; Russian Haemophilia Society President Yury Zhulev; and St. Petersburg Deputy Governor Oleg Ergashev, among others.

The main themes of the ‘Ensuring Drug Security’ Russian Pharmaceutical Forum in 2022 include the replacement of imported medicines and medical devices; boosting confidence in Russian medicines; the accessibility of innovative medicines for all types of patients; digitalization in drug supply; ways to ensure the quality, efficacy, and safety of drugs; and prospects for the development of the pharmaceutical market in Russia.

The Forum will conclude with the plenary session ‘Drug Security: Humanity at the Heart of Collaboration’. For Russia, drug security is currently a top priority in the healthcare sector and a precondition for the country to reach an entirely new level given the realities of the current challenges. The government’s immediate agenda includes maintaining the availability of medicines, ensuring the financial stability and technological independence of pharmaceutical industries, and fulfilling state guarantees for the provision of drugs to society. The plenary session participants will discuss what solutions will get the healthcare and medical supply industry out from the pressure of sanctions, what strategies for the import independence of the pharmaceutical industry are protecting the government’s interests, how the state and society can build a dialogue towards trust and cooperation, and how best to ensure national drug security and guarantee that Russian citizens regularly have high-quality and effective drugs available to them.

The partners of the ‘Ensuring Drug Security’ Russian Pharmaceutical Forum are the Promomed Group, Bristol Myers Squibb, and the Association of Pharmaceutical Manufacturers of the Eurasian Economic Union.

The general media partners of the Forum are the Doctor TV channel, Pharmaceutical Bulletin, and Medvestnik.

The media partners are Russia-1, RBC, the Remedium Group, GxP news, Healthcare of Russia, Russian Doctor Publishing House, and PharmMedProm.

Official website of the event: pharmforum.org.